Amarin Corporation plc - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AMRN Nasdaq 2830 www.amarincorp.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amarin Corporation plc

Amarin (AMRN) Q3 Results Recast Profit Story As Revenue Falls - Oct 29th, 2026 7:14 pm
Amarin's Q3 Earnings Beat Estimates, Revenues Miss Mark - Oct 29th, 2026 9:31 am
Amarin: Q3 Earnings Snapshot - Oct 28th, 2026 12:36 pm
Amarin (AMRN) Q3 2026 Earnings Call Transcript - Oct 28th, 2026 10:42 am
Amarin Returns to Quarterly Profit as Cost Reductions Offset 20% Revenue Decline - Oct 28th, 2026 10:02 am
European Equities Traded in the US as American Depositary Receipts Steady in Wednesday Trading - Oct 28th, 2026 9:15 am
What Amarin (AMRN) Said on Its Q3 Earnings Call - Oct 28th, 2026 8:04 am
Amarin Reports 2026 Third Quarter Financial Results, Achieves Positive Net Income - Oct 28th, 2026 5:00 am
Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal Cancer Liver Metastases (CRCLM) - Oct 25th, 2026 6:11 am
Amarin to Report Third Quarter 2026 Financial Results and Host Conference Call on October 28, 2026 - Oct 21st, 2026 6:00 am
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading - Oct 19th, 2026 9:13 am
FDA Expands ImmunityBio's Anktiva Label in Bladder Cancer - Oct 15th, 2026 9:56 am
Here's Why You Should Add EYPT Stock to Your Portfolio Now - Oct 15th, 2026 8:04 am
RARE's Fayuvi Approval Spurs Second PRV Sale Worth $203M in a Week - Oct 15th, 2026 7:33 am
LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label - Oct 14th, 2026 10:38 am
Here's Why You Should Add ANRO Stock to Your Portfolio Now - Oct 14th, 2026 6:59 am
Syndax Stock Falls 16% as Phase II Fibrosis Study Misses Primary Goal - Oct 14th, 2026 6:52 am
BMY Reports Mixed Phase III Trial Results, Stock Down - Oct 13th, 2026 10:40 am
Prime Medicine Stock Rallies Nearly 26% in a Month: Here's Why - Oct 12th, 2026 9:24 am